Candriam SCA’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,539
| Closed | -$2.95M | – | 822 |
|
|
2021
Q3 | $2.95M | Hold |
11,539
| – | – | 0.02% | 497 |
|
|
2021
Q2 | $7.68M | Buy |
11,539
+4,154
| +56% | +$2.77M | 0.05% | 327 |
|
|
2021
Q1 | $6.58M | Hold |
7,385
| – | – | 0.05% | 329 |
|
|
2020
Q4 | $6.85M | Sell |
7,385
-2,737
| -27% | -$2.54M | 0.05% | 337 |
|
|
2020
Q3 | $10.4M | Buy |
10,122
+1,566
| +18% | +$1.61M | 0.1% | 221 |
|
|
2020
Q2 | $8.67M | Sell |
8,556
-700
| -8% | -$709K | 0.09% | 239 |
|
|
2020
Q1 | $9.7M | Hold |
9,256
| – | – | 0.11% | 216 |
|
|
2019
Q4 | $9.93M | Sell |
9,256
-10,260
| -53% | -$11M | 0.11% | 218 |
|
|
2019
Q3 | $18M | Buy |
19,516
+17,476
| +857% | +$16.2M | 0.24% | 89 |
|
|
2019
Q2 | $2.29M | Sell |
2,040
-9,596
| -82% | -$10.8M | 0.03% | 484 |
|
|
2019
Q1 | $15.8M | Sell |
11,636
-2,400
| -17% | -$3.26M | 0.2% | 114 |
|
|
2018
Q4 | $16.2M | Sell |
14,036
-2,400
| -15% | -$2.78M | 0.25% | 90 |
|
|
2018
Q3 | $25M | Buy |
16,436
+8,912
| +118% | +$13.5M | 0.33% | 62 |
|
|
2018
Q2 | $11.8M | Buy |
7,524
+1,384
| +23% | +$2.17M | 0.19% | 141 |
|
|
2018
Q1 | $7.09M | Sell |
6,140
-400
| -6% | -$462K | 0.12% | 213 |
|
|
2017
Q4 | $7.75M | Sell |
6,540
-3,400
| -34% | -$4.03M | 0.13% | 193 |
|
|
2017
Q3 | $13.4M | Sell |
9,940
-4,500
| -31% | -$6.05M | 0.23% | 111 |
|
|
2017
Q2 | $11.7M | Sell |
14,440
-1,320
| -8% | -$1.07M | 0.22% | 124 |
|
|
2017
Q1 | $9.71M | Sell |
15,760
-2,640
| -14% | -$1.63M | 0.19% | 148 |
|
|
2016
Q4 | $9.84M | Sell |
18,400
-840
| -4% | -$449K | 0.23% | 122 |
|
|
2016
Q3 | $9.96M | Buy |
19,240
+8,400
| +77% | +$4.35M | 0.24% | 110 |
|
|
2016
Q2 | $4.45M | Sell |
10,840
-720
| -6% | -$295K | 0.12% | 201 |
|
|
2016
Q1 | $6.12M | Buy |
11,560
+1,160
| +11% | +$614K | 0.15% | 156 |
|
|
2015
Q4 | $7.92M | Buy |
10,400
+2,372
| +30% | +$1.81M | 0.21% | 123 |
|
|
2015
Q3 | $4.4M | Buy |
+8,028
| New | +$4.4M | 0.11% | 226 |
|